Microsoft

Microsoft (NASDAQ:MSFT) stock Analyst Ratings

Microsoft (NASDAQ:MSFT) stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/02/2024 23.76% Piper Sandler $425 → $455 Maintains Overweight 12/28/2023 22.4% Wedbush $425 → $450 Maintains Outperform 12/15/2023 22.4% Mizuho $420 → $450 Maintains Buy 12/13/2023 63.2% Truist Securities → $600 Initiates Coverage On → Buy 12/05/2023 16.96% Argus Research $390 → $430 Maintains Buy 12/05/2023 26.75% China Renaissance → $466 Initiates Coverage On → Buy 11/29/2023 29.2% Tigress Financial $433 → $475 Maintains Buy 11/24/2023 14.24% Mizuho $420 → $420 Reiterates Buy → Buy 11/24/2023 6.08% RBC Capital $390 → $390 Reiterates Outperform → Outperform 11/22/2023 15.6% Wedbush → $425 Reiterates Outperform → Outperform 11/20/2023 17.5% Evercore ISI Group → $432 Reiterates Outperform → Outperform 11/20/2023 10.16% Macquarie $405 → $405 Reiterates Outperform → Outperform 11/20/2023 15.6% Wedbush → $425 Reiterates Outperform → Outperform 11/16/2023 15.6% Wedbush $400 → $425 Maintains […]

Microsoft (NASDAQ:MSFT) stock Analyst Ratings Read Post »

Microsoft (NASDAQ:MSFT) Analyst Ratings

Microsoft (NASDAQ:MSFT) Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/15/2023 21.97% Mizuho $420 → $450 Maintains Buy 12/13/2023 62.63% Truist Securities → $600 Initiates Coverage On → Buy 12/05/2023 16.55% Argus Research $390 → $430 Maintains Buy 12/05/2023 26.31% China Renaissance → $466 Initiates Coverage On → Buy 11/29/2023 28.75% Tigress Financial $433 → $475 Maintains Buy 11/24/2023 13.84% Mizuho $420 → $420 Reiterates Buy → Buy 11/24/2023 5.71% RBC Capital $390 → $390 Reiterates Outperform → Outperform 11/22/2023 15.2% Wedbush → $425 Reiterates Outperform → Outperform 11/20/2023 17.1% Evercore ISI Group → $432 Reiterates Outperform → Outperform 11/20/2023 9.78% Macquarie $405 → $405 Reiterates Outperform → Outperform 11/20/2023 15.2% Wedbush → $425 Reiterates Outperform → Outperform 11/16/2023 15.2% Wedbush $400 → $425 Maintains Outperform 11/14/2023 15.2% Barclays $410 → $425 Maintains Overweight 10/30/2023 15.2% Piper Sandler → $425 Reiterates Overweight →

Microsoft (NASDAQ:MSFT) Analyst Ratings Read Post »

Microsoft Q1 2024 Earnings Call Transcript

Company Management Amy Hood – EVP & CFO Brett Iversen – VP, IR Satya Nadella – Chairman & CEO Analysts Bradley Sills – Bank of America Brent Bracelin – Piper Sandler Gregg Moskowitz – Mizuho Karl Keirstead – UBS Keith Weiss – Morgan Stanley Mark Moerdler – Bernstein Research. Raimo Lenschow – Barclays Keith Weiss Thank you for taking the question and very nice quarter. The pace of innovation you guys have been putting out has been pretty amazing. And the new products garnering traction probably faster than we’ve expected on our side of the equation. But we’re also working in an overall spending environment, that remains volatile, and I think investors are getting more concerned on it. So two questions on this, one, based on sort of the new products and the innovation, do you think you guys can sustain the type of commercial growth that we saw in

Microsoft Q1 2024 Earnings Call Transcript Read Post »

Microsoft Q1 EPS $2.99 Up From $2.35 YoY, Sales $56.50B Beat $51.40B Estimate

Microsoft (NASDAQ:MSFT) reported quarterly earnings of $2.99 per share. This is a 27.23 percent increase over earnings of $2.35 per share from the same period last year. The company reported quarterly sales of $56.50 billion which beat the analyst consensus estimate of $51.40 billion by 9.92 percent. This is a 12.72 percent increase over sales of $50.12 billion the same period last year.

Microsoft Q1 EPS $2.99 Up From $2.35 YoY, Sales $56.50B Beat $51.40B Estimate Read Post »

CFRA Keeps Strong Buy Opinion On Shares Of Microsoft Corp.

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month target at $407, based on a P/E of 30.7x our CY 25 EPS view, near its three- and five-year historical forward averages of 30.8x and 28.9x given our view of AI prospects. We hold our FY 24 (Jun.) EPS at $10.98 and FY 25 at $12.33. Ahead of Sep-Q earnings release set for 10/24, we see revenue growth of 8.8% ($54.5B) and EPS of $2.65. We think investors will be most interested to hear about commentary on Dec-Q guidance, updates on GenAI initiatives (sales/spending impact), and gaming outlook. For Dec-Q guidance, we see sales growth accelerating to +10%, on greater AI momentum and lapping steep Personal Computing declines. We project Azure growth of 26% in the Sep-Q (2 points from AI, up from

CFRA Keeps Strong Buy Opinion On Shares Of Microsoft Corp. Read Post »

Scroll to Top